|
ADRIAMYCIN-INDUCED
FETAL HYDRONEPHROSIS
(
Download pdf )
ANDERSON GONÇALVES,
WILLY G. FRANÇA, SUZANA G. MORAES, LUIS A.V. PEREIRA, LOURENÇO
SBRAGIA
Institute
of Biology and School of Medicine, State University of Campinas, UNICAMP,
Campinas,
São Paulo, Brazil
ABSTRACT
Introduction:
At the end of pregnancy, the amniotic fluid (AF) depends basically on
renal function, corresponding to fetal urine. Changes in AF, especially
oligohydramnios, are reported in association with fetal hydronephrosis
(FH). The experimental model using adriamycin in pregnant female rats
has a teratogenic effect and has been classically employed to study esophageal
atresia. Nevertheless, adriamycin promotes FH with high frequency as well.
In the present study, using this animal model, we tried to identify the
incidence and microscopic changes of FH, as well as its correlation with
AF weight.
Materials and Methods: Eight Spreague-Dawley
pregnant female rats received adriamycin 2.2 mg/kg on the 8th and 9th
gestational days (considering term gestation = 22 days). Those fetuses
that received adriamycin (Adriamycin Group) were compared with fetuses
from 2 female rats (Control Group), which received 0.9% saline solution.
On the 21.5 gestational day, the fetuses were collected by cesarean incision,
sacrificed, and examined for macro and microscopic changes in kidneys
and ureters. Fetuses with bilateral hydronephrosis formed the Hydronephrosis
Group. AF weight was determined as well.
Results: Hydronephrosis occurred in 70 (95%)
of the 74 fetuses in the adriamycin group against none of the 21 fetuses
from the control group. The amniotic fluid weight was increased in the
adriamycin group in relation to the control group (p < 0.001). The
histomorphometric study revealed dilation of the renal pelvis and reduction
of renal parenchyma in the hydronephrosis group in relation to the control
group. Severe cortical atrophy, cortical tubular atrophy and medullar
atrophy were observed in the hydronephrosis group.
Conclusions: Slight renal lesions were in
agreement with changes in AF weight, since they suggest that there was
production of urine with the maintenance of AF.
Key
words: rats; amniotic fluid; fetus; adriamycin; hydronephrosis
Int Braz J Urol. 2004; 30: 508-13
INTRODUCTION
The
amniotic fluid (AF) at the end of pregnancy depends basically on renal
function, corresponding to the fetal urine (1). Changes in AF concerning
volume, osmolarity and solute partition are reported in association with
fetal hydronephrosis (FH) (2-4).
FH is characterized by prenatal dilation
of the renal pelvis. Generally, it is associated with decreased urinary
flow, structural changes in renal parenchyma and impairment of renal function
(5,6). The clinical manifestation of FH is variable, presenting an unfavorable
outcome when it is bilateral or is associated with decrease in AF (oligohydramnios)
(2,7,8). Moreover, the prenatal assessment of AF has a predictive value
on the prognosis of the newborn (7,8).
The experimental model using adriamycin
in pregnant female rats has a teratogenic effect and has been classically
employed to study esophageal atresia. However, adriamycin promotes other
fetal morphologic changes, with FH being the urinary anomaly that occurs
with higher frequency (9-11). Much has been described about gastrointestinal
changes in the adriamycin model (12), however, little has been studied
about renal changes and their correlation with AF.
In the present study, we tried to identify
the feasibility of using adriamycin for the microscopic study of FH, aiming
to correlate renal microscopic changes with AF weight (AFw).
MATERIALS
AND METHODS
Eight
Spreague-Dawley pregnant female rats, weighting between 250 and 300 g,
received intra-peritoneal adriamycin 2.2 mg/kg on the 8th and 9th gestational
days (term = 22 days). The fetuses that received adriamycin (Adriamycin
Group) were compared with fetuses from 2 female rats (Control Group) that
had received 0.9% saline solution on the same gestational days.
On the day 21.5 of pregnancy, the rats underwent
a cesarean incision and the amniotic sac was integrally extracted and
weighted (ASw) in a precision balance. The amniotic sac was then excised
and the fetus (Fw), the placenta and the amniochorionic membranes (PMw)
were weighted separately. The AFw was obtained through the formula: AFw
= ASw - (Fw + PMw) in grams.
Then the fetuses were collected, sacrificed
and examined for macroscopic changes in kidneys and ureters, bladder changes,
and presence of proximal digestive atresias. Fetuses from the adriamycin
group with bilateral hydronephrosis formed the Hydronephrosis Group.
The abdominal region with the retroperitoneal
cavity of fetuses, containing kidneys and ureters, was fixed in formaldehyde
4% and included in paraffin. Semi-serial coronal histological sections
were obtained, measuring 5 µm, equidistant in 20 µm between
the anterior and posterior renal limits. Sections were stained with hematoxylin
and eosin.
Histomorphometric
Study and Qualitative Microscopic Analysis
The
fetal kidneys from the hydronephrosis group and the control group were
compared under light microscopy. Images obtained by microscopy were transmitted
to the computer via digital camera. Subsequently, they were dimensioned
using Image-Pro Plus 4.1 software (Media Cybernetics 1999), which allows
the gauging of linear measures and area after manually defining 2 points
and the perimeter, respectively. The micrometric scale was previously
defined by a calibration file, according to the microscope’s objective
lens.
With a X20 magnification, the 3 consecutive
sections of each left kidney were determined, where the diameters of the
ureteropelvic junction were largest. In these sections, the diameter of
the ureteropelvic junction, the mean parenchymal thickness, the area of
the renal pelvis, and the area of renal parenchyma were measured, and
the relationships between parenchyma and pelvis were established (Figure-1).
The histological changes of pelvic epithelium,
proximal ureter and kidney (epithelial, mesenchymal, epithelial-mesenchymal,
obstructive and inflammatory) were qualitatively analyzed according to
what is described in the literature for the model of obstructive hydronephrosis
(13,14).
Statistical
Analysis
The statistical analysis of weights, with
comparisons between the adriamycin and control groups, and the histomorphometric
measures, with comparisons between the hydronephrosis and control groups,
was performed through Mann-Whitney non-parametric test, considering the
difference as significant for p < 0.05 and highly significant for p
< 0.001.
RESULTS
Pregnancy
was confirmed in 10 female rats, with 8 forming the adriamycin group and
2 the control group. A total of 81 fetuses were obtained in the adriamycin
group, of which 74 (91%) were alive and 7 (9%) dead (4 were reabsorbed
and 3 were hydropic). In the control group, 21 fetuses were obtained,
all alive.
In the adriamycin group, hydronephrosis
(Figure-2) was observed in 70 out of 74 fetuses (95%), in addition to
other malformations. In the 21 fetuses from the control group, the malformations
under study were not observed (Table-1).
ASw, Fw and PMw were decreased and AFw was
increased in the adriamycin group in relation to the control group (p
< 0.001) (Table-2).
The histomorphometric study revealed pelvic
dilation and reduction of renal parenchyma in the hydronephrosis group
when compared with the control group (p < 0.001) (Table-3).
The qualitative microscopic analysis of
the kidneys in both groups demonstrated the capacity of distinguishing
between medullar and cortical in a lower magnification (X20) and the existence
of nephrogenic zone, composed by immature glomeruli (Figure-3). In the
hydronephrosis group, we observed severe cortical atrophy and tubular
cortical atrophy; as well as moderate caliceal dilation, moderate to severe
cystic tubular change and slight mesangial hyperplasia, whereas in the
control group such changes were not observed (Figure-4).
The search for microscopic changes in pelvis
and ureter revealed severe pelvic dilation with flattening of the epithelial
cells, and dilation and tortuosity of the proximal ureter in the hydronephrosis
group. On the other hand, no changes were observed in the ureteral epithelium,
which was similar to the control group.
COMMENTS
Adriamycin
acts on the S-phase of the cell cycle, inhibiting topoisomerase II and
consequently DNA synthesis (15). This inhibition induces cell apoptosis,
and is the potential molecular cause of the malformations detected, deriving
mostly from a failure in the embryologic development of mesoderma (16).
The decrease in ASw, Fw and PMw in the adriamycin
group in relation to the control group is due to the drug’s deleterious
effects, either by its primary action, or by the repercussions from the
malformations it induces (9,10).
The frequency of detected malformations
was similar to those found by other authors who used adriamycin (9-11,17).
Fetuses with serious renal defects leading
to intra-uterine urinary retention evolve with oligohydramnios, due to
the relation between the production of fetal urine and a proper amount
of AF (3,7). Despite bilateral FH occurring in 87% of fetuses in the adriamycin
group, there was an increase in AFw in relation to the control group (p
< 0.0001). However, a bilateral FH occurred in association with 100%
of digestive atresias. Such atresias, especially proximal ones, impair
the deglutition of AF, as well as its absorption in the gastrointestinal
tract, and may lead to polyhydramnios (18).
The association between these anomalies,
intestinal atresias and FH, which have a contrary effect on AFw, and other
potential causes of oligohydramnios can make results controversial. However,
the present study showed that the ability of forming urine, and consequently
AF by the fetal kidney was preserved, since there was no decrease in the
AFw. Hence, it is not important to say that AFw increased, but that it
did not decrease, since little AF would indicate low production of fetal
urine.
Merei et al. (2001) studied urinary malformations
in the adriamycin model and concluded that the ureters would present a
blind end, producing hydronephrotic fetal kidneys and altering the normal
development of urinary bladder (11). In order to explain the increase
in AF that occurs concomitantly in blind-ending ureters, extra-renal compensatory
mechanisms would be required.
Liu & Hutson (2000), while studying
urogenital malformations in the same model, concluded that the ureters
might communicate with the urethra in male fetuses, and with the urogenital
sinus in female fetuses, through an uretero-ureteral or uretero-urogenital
fistula, respectively (19). Thus, urinary flow would occur, which would
allow for a proper maintenance of AF amount. The occurrence of FH non-associated
with oligohydramnios is suitable with the explanations proposed by Liu
& Hutson (2000), since it may be the indirect result of passage of
urine to the amniotic cavity (19).
In relation to bladder development, the
occurrence of 84% of bladder hypoplasia observed in the present study
could be explained both by the lack of filling due to fistula between
ureter and urethra or urogenital sinus and by the presence of blind-ending
ureter (11,19).
Liu et al. (1999) studied bladder development,
using adriamycin and verified that the 7th gestational day is the critical
time when the drug administration causes bladder agenesis. Bladder hypoplasia
observed in the present study, considering that the drug was administered
on the 8th and 9th days, must be consequent to ureteral defects or represent
an effectively distinct anomaly from that observed by the same author
(20).
The histomorphometric study revealed increase
in the ureteropelvic junction (UPJ) diameter and in pelvic area, and decrease
of parenchymal thickness and parenchymal area in the hydronephrosis group
when compared with the control group. The parenchyma/pelvis relationships
were decreased to half in the hydronephrosis group in relation to the
control group, when we used linear measures decreased to one third, when
area measurements were used. These results objectively confirm the pelvic
dilation and decrease in renal parenchyma observed in kidneys with hydronephrosis.
In models of surgically created hydronephrosis,
we detected epithelial, epithelial-mesenchymal, obstructive and inflammatory
changes, including atrophy, dysplasia, fibrosis and changes in the renal
development (3,13,14).
Microscopic findings in the present study
are milder than the ones reported in those works, being restricted to
the mechanical repercussion of urine retention, which is characterized
by dilation of ureter, pelvis and ducts, and to secondary mass changes,
such as atrophy of cortex and medulla. Moreover, no inflammatory or developmental
changes were observed.
Other changes were expected in addition
to dilation, since urine retention can be associated with renal damage
and impair its normal differentiation (6,14). However, the microscopic
findings are in agreement with other findings relative to AFw, which indirectly
revealed production of fetal urine.
CONCLUSION
The
experimental model of induction by adriamycin showed to be feasible for
the microscopic study of fetal hydronephrosis. The microscopic changes,
despite being milder than the lesions described for surgically produced
fetal hydronephrosis, were in agreement with amniotic fluid weight, since
they enabled the production of urine with maintenance of the amniotic
fluid.
_____________________________________
Anderson Gonçalves received scholarship for
Scientific Initiation from CNPq, and Lourenço
Sbragia Neto from FAPESP
REFERENCES
- Brace RA: Physiology of amniotic fluid volume regulation. Clin Obstet
Gynecol. 1997; 40: 280-9.
- Harrison MR, Nakayama DK, Noall R, de Lorimier AA: Correction of
congenital hydronephrosis in utero II. Decompression reverses the effects
of obstruction on the fetal lung and urinary tract. J Pediatr Surg.
1982; 17: 965-74.
- Chevalier RL, Thornhill BA, Chang AY: Unilateral ureteral obstruction
in neonatal rats leads to renal insufficiency in adulthood. Kidney Int.
2000; 58: 1987-95.
- Seseke F, Thelen P, Hemmerlein B, Kliese D, Zoller G, Ringert RH:
Histologic and molecular evidence of obstructive uropathy in rats with
hereditary congenital hydronephrosis. Urol Res. 2000; 28: 104-9.]
- Freedman AL, Bukowski TP, Smith CA, Evans MI, Johnson MP, Gonzalez
R: Fetal therapy for obstructive uropathy: diagnosis specific outcomes
[corrected]. J Urol. 1996; 156 (2 Pt 2): 720-3; discussion 723-4; Erratum
in: J Urol. 1996; 156: 1786.
- Bernstein J, Risdon RA, Gilbert-Barness E: Renal System. In: Gilbert-Barness
E (ed.), Potter’s, Pathology of the Fetus and Infant. St Louis,
Mosby. 1997; pp. 863-903.
- Bastide A, Manning F, Harman C, Lange I, Morrison I: Ultrasound evaluation
of amniotic fluid: outcome of pregnancies with severe oligohydramnios.
Am J Obstet Gynecol. 1986; 154: 895-900.
- Reddy PP, Mandell J: Prenatal diagnosis. Therapeutic implications.
Urol Clin North Amer. 1998; 25: 171-80.
- Beasley SW, Diez Pardo J, Qi BQ, Tovar JA, Xia HM: The contribution
of the adriamycin-induced rat model of the VATER association to our
understanding of congenital abnormalities and their embryogenesis. Pediatr
Surg Int. 2000; 16: 465-72.
- Merei J, Hasthorpe S, Farmer P, Hutson JM: Visceral anomalies in
prenatally adriamycin-exposed rat fetuses: a model for the VATER association.
Pediatr Surg Int. 1999; 15: 11-6.
- Merei J, Batiha A, Hani IB, El-Qudah M: Renal anomalies in the VATER
animal model. J Pediatr Surg. 2001; 36: 1693-7.
- Franca WM, Goncalves A, Moraes SG, Pereira LA, Sbragia L: Esophageal
atresia and other visceral anomalies in a modified Adriamycin rat model
and their correlations with amniotic fluid volume variations. Pediatr
Surg Int. 2004; 20: 602-8.
- Steinhardt GF, Liapis H, Phillips B, Vogler G, Nag M, Yoon KW: Insulin-like
growth factor improves renal architecture of fetal kidneys with complete
ureteral obstruction. J Urol. 1995; 154: 690-3.
- Steinhardt GF, Salinas-Madrigal L, deMello D, Farber R, Phillips
B, Vogler G: Experimental ureteral obstruction in the fetal Opossum:
histologic assessment. J Urol. 1994; 152: 2133-8.
- Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF: Adriamycin-induced
DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984;
226 (4673): 466-8.
- Orford JE, Cass DT: Dose response relationship between adriamycin
and birth defects in a rat model of VATER association. J Pediatr Surg.
1999; 34: 392-8.
- Beasley SW, Diez Pardo J, Qi BQ, Tovar JA, Xia HM: The contribution
of the adriamycin-induced rat model of the VATER association to our
understanding of congenital abnormalities and their embryogenesis. Pediatr
Surg Int. 2000; 16: 465-72.
- Kimble RM, Harding JE, Kolbe A: Does gut atresia cause polyhydramnios?
Pediatr Surg Int. 1998; 13: 115-7.
- Liu MI, Hutson JM: Cloacal and urogenital malformations in adriamycin-exposed
rat fetuses. BJU Int. 2000; 86: 107-12.
- Liu MI, Hutson JM, Zhou B: Critical timing of bladder embryogenesis
in an adriamycin-exposed rat fetal model: a clue to the origin of the
bladder. J Pediatr Surg. 1999; 34: 1647-51.
______________________
Received: August 23, 2004
Accepted after revision: November 17, 2004
_______________________
Correspondence address:
Dr. Lourenço Sbragia Neto
Discipline of Pediatric Surgery, FCM, Unicamp
Rua Alexander Fleming, 181, Barão Geraldo
Campinas, SP, 13084-970, Brazil
Fax: + 55 19 3788-9473
E-mail: sbragia@fcm.unicamp.br |